secwatch / observer
8-K filed May 16, 2024, 7:59 PM ET ticker TVGN CIK 0001860871
debt confidence high sentiment neutral materiality 0.75

Tevogen Bio enters $36M line of credit with Patel Family; also grants PIPE option for $14M+

Tevogen Bio Holdings Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Tevogen Bio Holdings Inc. entered into Term Sheet for Unsecured Line of Credit Facility and Contingent PIPE Option with The Patel Family, LLP valued at up to $36.0 million unsecured line of credit facility; contingent option for $14.0 million private p (effective 2024-05-10).

Action
entry
Agreement
credit facility
Counterparty
The Patel Family, LLP
Value
up to $36.0 million unsecured line of credit facility; contingent option for $14.0 million private p
Effective
2024-05-10
Exact text from the filing
On May 10, 2024, Tevogen Bio Holdings Inc. (the “Company”) entered into a binding term sheet (the “Term Sheet”) setting forth the Company’s principal understanding and agreement with The Patel Family, LLP (the “Lender”) with respect to (i) an unsecured line of credit facility (the “Facility”) pursuant to which the Lender will agree to lend the Company up to $36.0 million (the “Maximum Loan Amount”) and (ii) a contingent option for the Lender to purchase at least $14.0 million of the Company’s common stock in a future private placement (the “PIPE”).
View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

Tevogen Bio Holdings Inc. filing history →

Source: SEC EDGAR
accession 0001493152-24-020275
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.